Kishore M. Gadde
Obesity Clinical Trials Programme
Duke University Medical Center
Durham
NC 27710
USA
Name/email consistency: high
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Gadde, K.M., Allison, D.B., Ryan, D.H., Peterson, C.A., Troupin, B., Schwiers, M.L., Day, W.W. Lancet (2011)
- Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. Gadde, K.M., Yonish, G.M., Foust, M.S., Wagner, H.R. J. Clin. Psychiatry (2007)
- Escitalopram treatment of trichotillomania. Gadde, K.M., Ryan Wagner, H., Connor, K.M., Foust, M.S. Int. Clin. Psychopharmacol (2007)
- Bupropion for weight reduction. Gadde, K.M., Xiong, G.L. Expert. Rev. Neurother (2007)
- Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial. Gadde, K.M., Yonish, G.M., Wagner, H.R., Foust, M.S., Allison, D.B. Int. J. Obes. (Lond) (2006)
- Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial. Gadde, K.M., Zhang, W., Foust, M.S. J. Clin. Psychopharmacol (2006)
- Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks. Gadde, K.M., Allison, D.B. Circulation (2006)
- Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reduction. Gadde, K.M. Curr. Drug. Targets. Cardiovasc. Haematol. Disord (2005)
- Zonisamide for weight loss in obese adults: a randomized controlled trial. Gadde, K.M., Franciscy, D.M., Wagner, H.R., Krishnan, K.R. JAMA (2003)
- Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Gadde, K.M., Parker, C.B., Maner, L.G., Wagner, H.R., Logue, E.J., Drezner, M.K., Krishnan, K.R. Obes. Res. (2001)